Lv1
18 积分 2025-08-28 加入
Glucagon-Like Peptide 1 Receptor Agonists and Age-Related Macular Degeneration Incidence
1个月前
已完结
Data and Temporal Risk Concerns of Semaglutide and NAION
2个月前
已完结
Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes
2个月前
已完结
Should We Be Concerned About Glucagon-Like Peptide-1 Receptor Agonists?
5个月前
已完结
Glucagon-Like Peptide-1 Receptor Agonist Use and Age-Related Macular Degeneration—Where Do We Stand?
7个月前
已关闭
Talks and tweets from the ADA
9个月前
已完结
Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes
9个月前
已完结
GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis
9个月前
已完结
Melatonin mitigates disrupted circadian rhythms, lowers intraocular pressure, and improves retinal ganglion cells function in glaucoma
10个月前
已完结
IGFBPL1 is a master driver of microglia homeostasis and resolution of neuroinflammation in glaucoma and brain tauopathy
11个月前
已完结
皖公网安备34019202002308
